Gilead Stock Surges on Strong Results in HIV Drug Study [Yahoo! Finance]
Gilead Sciences, Inc. (GILD)
Last gilead sciences, inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.gilead.com
Company Research
Source: Yahoo! Finance
Gilead said the test results were so significant an independent monitor recommended the company give the drug to all participants. More testing is needed before Gilead can apply to the U.S. Food and Drug Administration for approval. Shares of Gilead surged Thursday following the news. Gilead Sciences ( GILD ) surged over 8% in intraday trading Thursday as the biotech firm announced a Phase 3 trial found its injectable lenacapavir was 100% effective in preventing HIV infection in women. Gilead noted that the results were so successful that the independent Data Monitoring Committee (DMC) recommended that the company end the blind phase of the study and offer lenacapavir to all of the participants. Zero HIV Infections Among Women Who Took Gilead's Lenacapavir The trial found zero cases of HIV infection among the 2,134 women who received the treatment, versus several cases among those who took Gilead's current HIV pills, Truvada and Descovy. Truvada was the first pre-exposure
Show less
Read more
Impact Snapshot
Event Time:
GILD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GILD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GILD alerts
High impacting Gilead Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
GILD
News
- Gilead Sciences (GILD) Stock Slides as Market Rises: Facts to Know Before You Trade [Yahoo! Finance]Yahoo! Finance
- Gilead Sciences Recalls One Lot Of Its COVID-19 Treatment Due To Presence Of Glass Particles [Yahoo! Finance]Yahoo! Finance
- IBBQ: This Low-Cost Biotech ETF Comes With Unique Risks [Seeking Alpha]Seeking Alpha
- Gilead Sciences, Verizon Communications And ManpowerGroup Are Winners For Passive Income [Yahoo! Finance]Yahoo! Finance
- High Growth Tech Stocks To Watch This September 2024 [Yahoo! Finance]Yahoo! Finance
GILD
Earnings
- 8/8/24 - Beat
GILD
Sec Filings
- 9/13/24 - Form 4
- 9/13/24 - Form 4
- 9/12/24 - Form 144
- GILD's page on the SEC website